Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 5, 2001, Pages 1444-1449

  Lenzo, J C ^a   Shellam, G R ^a   Lawson, C M ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; GANCICLOVIR;

ACUTE DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG EFFICACY; INFLAMMATION; MALE; MOUSE; MUSCLE NECROSIS; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIVIRAL AGENTS; CYTOSINE; DISEASE MODELS, ANIMAL; GANCICLOVIR; HERPESVIRIDAE INFECTIONS; MALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MUROMEGALOVIRUS; MYOCARDITIS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 0035038014     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.5.1444-1449.2001     Document Type: Article

References (36)

1. Antiviral properties of a series of 1,6-naphthyridine and 7,8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirus
2. Acute murine cytomegalovirus infection: A model for determining antiviral activity against CMV induced hepatitis
3. Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy
4. Safety considerations in the use of ganciclovir in immunocompromised patients
5. Cytomegalovirus drug resistance
6. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin
7. Activity of 9-(1,3-dihydroxy-2-propoxymethyl) guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses
8. The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy
9. Coxsackievirus B3 infection leads to cell death of cardiac myocytes
10. Intracellular metabolism of the antiherpes agent (s)-1-[3-hydroxy-2-(phosphonymethoxy) propyl] cytosine
11. Autoimmunity in myocarditis: Relevance of animal models
12. Molecular mechanisms in the pathogenesis of enteroviral heart disease: Acute, and persistent infections
13. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analysis of lymphocyte subsets
14. The role of enterovirus replication in the development of acute and chronic muscle disease in different immunocompetent mouse strains
15. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis
16. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice
17. Genetic control of mouse cytomegalovirus-induced myocarditis
18. Mouse cytomegalovirus infection induces antibodies which cross react with virus and cardiac myosin: A model for the study of molecular mimicry in the pathogenesis of viral myocarditis
19. Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice
20. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir
21. Cytomegalovirus associated inflammatory heart muscle disease
22. Direct myocardial injury by enterovirus: A central role in the evolution of murine myocarditis
23. Viral myocarditis leading to cardiomyopathy: Do cytokines contribute to pathogenesis?
24. Metabolism of ganciclovir and cidofovir in cells infected with drug-resistant and wild-type strains of murine cytomegalovirus
25. Myocarditis - From infection to autoimmunity
26. The pathogenesis of postinfectious myocarditis
27. Coxsackievirus myocarditis
28. Post infectious autoimmunity: Two distinct phases of Coxsackievirus B3-induced myocarditis
29. Clinical uses of cidofovir
30. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions
31. Viral myocarditis
32. Lymphocytes protect against and are not required for reovirus-induced myocarditis
33. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl) guanine and acyclovir in herpes simplex virus-infected and uninfected cells
34. Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases
35. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma
36. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase